Hugues Wallemacq

Company: EXO Biologics

Job title: Chief Operating Officer

Seminars:

From R&D to GMP Exosomes Mass Production for Ongoing Clinical Phase I/II & Inflammation Related Indications 11:30 am

• Key elements to take into account during R&D and preclinical not lose years and funds in GMP transition process • How to produce enough exosomes in a GMP compliant way to answer clinical trial demand • What does the regulatory pathway looks like in Europe to start phase I/IIRead more

day: Day One Track B AM